Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA)

Clinica Chimica Acta

Volumn 393, Issue 2, 2008, Pages 95-102

  Hamrita, Bechr ^a   Chahed, Karim ^a,b   Kabbage, Maria ^a   Guillier, Christelle Lemaitre ^c   Trimeche, Mounir ^d   Chaïeb, Anouar ^d   Chouchane, Lotfi ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c CNRS   (France)

^d FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Autoantibody; Infiltrating ductal carcinomas; Serological proteome analysis; Tumor antigen

Indexed keywords

BETA TUBULIN; CHAPERONE; CYTOKERATIN 18; CYTOKERATIN 8; F ACTIN; HAPTOGLOBIN; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN G ANTIBODY; MANGANESE SUPEROXIDE DISMUTASE; PEROXIREDOXIN; PROHIBITIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TUMOR ANTIGEN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; CANCER INVASION; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOREACTIVITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEOMICS; SEROLOGY; SERUM; TUMOR IMMUNITY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BLOOD PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 44449130082     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.03.017     Document Type: Article

References (35)

1. Parkin D.M., Ferlay J., Hamdi cherif M., et al. Cancer in Africa: epidemiology and prevention. IARC Scientific publications (2003), IARC Press, Lyon, France 262-267
2. Hondermarck H. Breast cancer. Mol Cell Proteomics 2 (2003) 281-291
3. Adkins J.N., Varnum S.M., Auberry K.J., et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1 (2002) 917-955
4. Madrid F.F. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis. Cancer lett 230 (2005) 187-198
5. Brichory F., Beer D., Le Naour F., Giordano T., and Hanash S. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res 61 (2001) 7908-7912
6. Yang F., Xiao Z.Q., Zhang X.Z., et al. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J Prot Res 6 (2007) 751-758
7. Takashima M., Kuramitsu Y., Yokoyama Y., et al. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 6 (2006) 3894-3900
8. Fujita Y., Nakanishi T., Hiramatsu M., et al. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Clin Cancer Res 12 (2006) 6415-6420
9. Pavoni E., Pucci A., Vaccaro P., et al. A study of the humoral immune response of breast cancer patients to a panel of human tumor antigens identified by phage display. Cancer Detect Prev 30 (2006) 248-256
10. Le Naour F., Misek D.E., Krause M.C., et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 7 (2001) 3325-3327
11. Chahed K., Kabbage M., Sabatier L., et al. Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: The two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses. Int J Oncol 27 (2005) 1425-1431
12. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68 (1996) 850-858
13. Chung Y.M., Yoo Y.D., Park J.K., Kim Y.T., and Kim H.J. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res 21 (2001) 1129-1133
14. Chang J.W., Lee S.H., Jeong J.Y., et al. Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett 579 (2005) 2873-2877
15. Nagai M., Hasegawa M., Takehara K., and Sato S. Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma. J Invest Dermatol 122 (2004) 594-601
16. Barazi H.O., Zhou L., Templeton N.S., Krutzsch H.C., and Roberts D.D. Identification of heat shock protein 60 as a molecular mediator of alpha 3 beta 1 integrin activation. Cancer Res 62 (2002) 1541-1548
17. Li D.Q., Wang L., Fei F., et al. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics 6 (2006) 3352-3368
18. Ranford J.C., and Henderson B. Chaperonins in disease: mechanisms, models, and treatments. Mol Pathol 55 (2002) 209-213
19. Alard J.E., Dueymes M., Youinou P., and Jamin C. Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun 6 (2007) 438-443
20. Vigontina O.G., Efimenko O.A., Yakovenko L.F., et al. Chaperon HSP-60 as autoantigen in development of dyshormonal breast diseases. Exp Oncol 24 (2002) 112-115
21. Canelle L., Bousquet J., Pionneau C., et al. An efficient proteomics-based approach for the screening of autoantibodies. J Immunol Methods 299 (2005) 77-89
22. Conroy S.E., Sasieni P.D., Fentiman I., and Latchman D.S. Autoantibodies to the 90 kDa heat shock protein and poor survival in breast cancer patients. Eur J Cancer 34 (1998) 942-943
23. Le Naour F., Brichory F., Misek D.E., Bréchot C., Hanash S.M., and Beretta L. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol Cell Proteomics 1 (2002) 197-203
24. Cui J.W., Li W.H., Wang J., et al. Proteomics-based identification of human acute leukemia antigens that induce humoral immune response. Mol Cell Proteomics 4 (2005) 1718-1724
25. Jalbout M., Bel Hadj Jrad B., et al. Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma. Int J Cancer 101 (2002) 146-150
26. Murota M., Nishioka M., Fujita J., et al. Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis. Clin Exp Immunol 125 (2001) 291-299
27. Dobashi N., Fujita J., Ohtsuki Y., et al. Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders. Thorax 53 (1998) 969-974
28. Kurki P., and Virtanen I. The detection of human antibodies against cytoskeletal components. J Immunol Methods 67 (1984) 209-223
29. Fusaro G., Dasgupta P., Rastogi S., Joshi B., and Chellappan S. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem 278 (2003) 47853-47861
30. Goodell V., Salazar L.G., Urban N., et al. Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer. J Clin Oncol 24 (2006) 762-768
31. Sato T., Saito H., Swensen J., et al. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res 52 (1992) 1643-1646
32. Mandal M., Vadlamudi R., Nguyen D., et al. Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem 276 (2001) 9699-9704
33. Levine J.S., and Koh J.S. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant. Semin Nephrol 19 (1999) 34-47
34. Kuhajda F.P., Katumuluwa A.I., and Pasternack G.R. Expression of haptoglobin-related protein and its potential role as a tumor antigen. Proc Natl Acad Sci USA 86 (1989) 1188-1192
35. Epelbaum R., Shalitin C., Segal R., et al. Haptoglobin-related protein as a serum marker in malignant lymphoma. Pathol Oncol Res 4 (1998) 271-276